预测小于胎龄儿:基于母体因素、胎儿生物测量和生物标志物在妊娠35-37周的筛查
本研究基于19,209例单胎妊娠,在35+0-36+6周筛查时,利用母体因素、超声估计胎儿体重及胎盘功能相关生物标志物构建预测小于胎龄儿(SGA)的模型。在验证集中,仅用母体因素预测90%的SGA新生儿(评估后2周内分娩)的筛查阳性率为67%,加入估计胎儿体重后降至23%,再添加生物标志物后降至21%。结论认为生物标志物仅轻微改善基于母体因素和胎儿生物测量的预测性能。
要点
- 在35+0-36+6周,仅用母体因素预测90%的SGA(2周内分娩)需筛查阳性率67%,加入EFW后降至23%。
- 在母体因素和EFW基础上添加生物标志物,筛查阳性率仅从23%降至21%(2周内分娩)。
- 对于评估后任何阶段分娩的SGA,母体因素+EFW+生物标志物的筛查阳性率为30%。
核心结论
- 在35+0-36+6周妊娠,添加胎盘功能受损的生物标志物仅轻微改善基于母体因素和胎儿生物测量对SGA新生儿分娩的预测性能。
研究设计与样本
- 研究纳入19,209例在35+0-36+6周接受筛查的单胎妊娠,数据集分为训练集和验证集。
- 训练集用于通过多变量逻辑回归分析开发模型,评估在母体因素和估计胎儿体重(EFW)基础上添加子宫动脉搏动指数(UtA-PI)、脐动脉PI(UA-PI)、胎儿大脑中动脉PI(MCA-PI)、母体血清胎盘生长因子(PlGF)和可溶性fms样酪氨酸激酶-1(sFLT)是否改善预测性能。
- 模型在验证集中测试以评估筛查性能。
主要发现
- 在训练集的SGA组中,与出生体重≥第10百分位者相比,PlGF和MCA-PI的中位数倍数(MoM)值降低,而UtA-PI、UA-PI和sFLT升高。
- 多变量回归分析显示,在预测第10百分位以下的SGA时,母体因素、EFW Z评分、UtA-PI MoM、MCA-PI MoM和PlGF MoM有显著贡献。
- 在验证集中,预测90%的SGA新生儿在评估后2周内分娩,筛查阳性率:仅母体因素为67%(95%CI 64-70%),母体因素+EFW为23%(95%CI 20-26%),再加生物标志物为21%(95%CI 19-24%)。
- 预测90%的SGA新生儿在评估后任何阶段分娩,筛查阳性率:仅母体因素为66%(95%CI 65-67%),母体因素+EFW为32%(95%CI 31-33%),再加生物标志物为30%(95%CI 29-31%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small for gestational age (SGA) neonates are at increased risk for perinatal mortality and morbidity; however, the risks can be substantially reduced if the condition is identified prenatally, because in such cases close monitoring and appropriate timing of delivery and prompt neonatal care can be undertaken. The traditional approach of identifying pregnancies with SGA fetuses is maternal abdominal palpation and serial measurements of symphysial-fundal height, but the detection rate of this approach is less than 30%. A higher performance of screening for SGA is achieved by sonographic fetal biometry during the third trimester; screening at 30-34 weeks' gestation identifies about 80% of SGA neonates delivering preterm but only 50% of those delivering at term, at a screen-positive rate of 10%. There is some evidence that routine ultrasound examination at 36 weeks' gestation is more effective than that at 32 weeks in predicting birth of SGA neonates. OBJECTIVE: To investigate the potential value of maternal characteristics and medical history, sonographically estimated fetal weight (EFW) and biomarkers of impaired placentation at 35+0- 36+6 weeks' gestation in the prediction of delivery of SGA neonates. MATERIALS AND METHODS: A dataset of 19,209 singleton pregnancies undergoing screening at 35+0-36+6 weeks' gestation was divided into a training set and a validation set. The training dataset was used to develop models from multivariable logistic regression analysis to determine whether the addition of uterine artery pulsatility index (UtA-PI), umbilical artery PI (UA-PI), fetal middle cerebral artery PI (MCA-PI), maternal serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFLT) would improve the performance of maternal factors and EFW in the prediction of delivery of SGA neonates. The models were then tested in the validation dataset to assess performance of screening. RESULTS: First, in the training dataset, in the SGA group, compared to those with birthweight in ≥10th percentile, the median multiple of the median (MoM) values of PlGF and MCA-PI were reduced, whereas UtA-PI, UA-PI, and sFLT were increased. Second, multivariable regression analysis demonstrated that in the prediction of SGA in <10th percentile there were significant contributions from maternal factors, EFW Z-score, UtA-PI MoM, MCA-PI MoM, and PlGF MoM. Third, in the validation dataset, prediction of 90% of SGA neonates delivering within 2 weeks of assessment was achieved by a screen-positive rate of 67% (95% confidence interval [CI], 64-70%) in screening by maternal factors, 23% (95% CI, 20-26%) by maternal factors, and EFW and 21% (95% CI, 19-24%) by the addition of biomarkers. Fourth, prediction of 90% of SGA neonates delivering at any stage after assessment was achieved by a screen-positive rate of 66% (95% CI, 65-67%) in screening by maternal factors, 32% (95% CI, 31-33%) by maternal factors and EFW and 30% (95% CI, 29-31%) by the addition of biomarkers. CONCLUSION: The addition of biomarkers of impaired placentation only marginally improves the predictive performance for delivery of SGA neonates achieved by maternal factors and fetal biometry at 35+0-36+6 weeks' gestation.
引用
- Ciobanu A, Rouvali A, Syngelaki A, et al. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation. Am J Obstet Gynecol. 2019. PMID: 30707967. doi:10.1016/j.ajog.2019.01.227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。